In this study, we have explored the hypothesis that circulating FABP4 levels are associated with the biomarkers of HF, such as the N-terminal fragment of pro-B-type natriuretic peptide (NT-proBNP), and with HF clinical parameters. Here, FABP4 is linked to hydrops fetalis.